Cargando…
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis
BACKGROUND: A limited number of targeted therapy options exist for papillary thyroid cancer (PTC) to date. Based on genetic alterations reported by the “The Cancer Genome Atlas (TCGA)”, we explored whether PTC shows alterations that may be targetable by drugs approved by the FDA for other solid canc...
Autores principales: | Hescheler, Daniel A., Riemann, Burkhard, Hartmann, Milan J. M., Michel, Maximilian, Faust, Michael, Bruns, Christiane J., Alakus, Hakan, Chiapponi, Costanza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498581/ https://www.ncbi.nlm.nih.gov/pubmed/34630336 http://dx.doi.org/10.3389/fendo.2021.748941 |
Ejemplares similares
-
Anaplastic thyroid cancer: genome-based search for new targeted therapy options
por: Hescheler, Daniel Alexander, et al.
Publicado: (2022) -
Targeted Therapy for Adrenocortical Carcinoma: A Genomic-Based Search for Available and Emerging Options
por: Hescheler, Daniel Alexander, et al.
Publicado: (2022) -
Hürthle Cell Carcinoma: Single Center Analysis and Considerations for Surgical Management Based on the Recent Literature
por: Chiapponi, Costanza, et al.
Publicado: (2022) -
Lymphatic Vessel Invasion in Routine Pathology Reports of Papillary Thyroid Cancer
por: Chiapponi, Costanza, et al.
Publicado: (2022) -
Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse
por: Chiapponi, Costanza, et al.
Publicado: (2021)